ES2794082T3 - Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis - Google Patents

Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis Download PDF

Info

Publication number
ES2794082T3
ES2794082T3 ES14860161T ES14860161T ES2794082T3 ES 2794082 T3 ES2794082 T3 ES 2794082T3 ES 14860161 T ES14860161 T ES 14860161T ES 14860161 T ES14860161 T ES 14860161T ES 2794082 T3 ES2794082 T3 ES 2794082T3
Authority
ES
Spain
Prior art keywords
dimer
pancreatitis
seq
individual
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14860161T
Other languages
English (en)
Spanish (es)
Inventor
Xiaoqiang Yan
Cheng Huang
Dongdong Wu
Kaiyang Tang
Yuliang Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generon Shanghai Corp Ltd
Original Assignee
Generon Shanghai Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generon Shanghai Corp Ltd filed Critical Generon Shanghai Corp Ltd
Application granted granted Critical
Publication of ES2794082T3 publication Critical patent/ES2794082T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES14860161T 2013-11-07 2014-11-06 Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis Active ES2794082T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310549648.XA CN104623639A (zh) 2013-11-07 2013-11-07 白介素22二聚体在制备治疗胰腺炎药物中的应用
PCT/CN2014/090519 WO2015067198A1 (en) 2013-11-07 2014-11-06 Use of il-22 dimers in manufacture of medicaments for treating pancreatitis

Publications (1)

Publication Number Publication Date
ES2794082T3 true ES2794082T3 (es) 2020-11-17

Family

ID=53040916

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14860161T Active ES2794082T3 (es) 2013-11-07 2014-11-06 Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis

Country Status (8)

Country Link
US (1) US20160271221A1 (enExample)
EP (1) EP3065765B1 (enExample)
JP (2) JP6825181B2 (enExample)
CN (2) CN104623639A (enExample)
AU (1) AU2014346051B2 (enExample)
CA (1) CA2929637C (enExample)
ES (1) ES2794082T3 (enExample)
WO (1) WO2015067198A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361968B (zh) 2007-08-06 2011-08-03 健能隆医药技术（上海）有限公司 白介素-22在治疗脂肪肝中的应用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
CN106146668A (zh) * 2015-04-01 2016-11-23 中国人民解放军第二军医大学 长效白细胞介素22的制备方法及其用途
US10851133B2 (en) * 2015-06-08 2020-12-01 New York University Stabilized minimal coiled-coil mimetics
RU2018105687A (ru) * 2015-07-16 2019-08-16 Филоджен С.П.А. Иммуноконъюгаты на основе il22
WO2017181143A1 (en) 2016-04-15 2017-10-19 Generon (Shanghai) Corporation, Ltd. Use of il-22 in treating necrotizing enterocolitis
WO2020055768A1 (en) 2018-09-10 2020-03-19 Cold Spring Harbor Laboratory Methods for treating pancreatitis
CN110302363B (zh) * 2019-07-04 2020-10-09 北京大学第三医院（北京大学第三临床医学院） Il-22作为制备治疗pcos药物的应用及药物制剂
EP4106794A4 (en) * 2020-02-19 2024-03-20 Evive Biotechnology (Shanghai) Ltd METHOD FOR TREATING TRANSPLANT AND HOST DISEASE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503950A (ja) 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
EP1002529A1 (en) 1994-09-09 2000-05-24 Takeda Chemical Industries, Ltd. Sustained-release preparation containing a metal salt of a peptide
SK281571B6 (sk) 1995-06-07 2001-05-10 Alkermes Controlled Therapeutics, Inc. Prostriedok na trvalé uvoľňovanie ľudského rastového hormónu
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US6274710B1 (en) 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
CN102380091A (zh) 2010-08-31 2012-03-21 健能隆医药技术（上海）有限公司 白介素-22在治疗病毒性肝炎中的应用
US8690554B2 (en) * 2011-07-15 2014-04-08 Xylem Ip Holdings Llc Diaphragm pump using duckbill and other types of valves
PL2970422T3 (pl) * 2013-03-15 2018-09-28 F.Hoffmann-La Roche Ag Polipeptydy IL-22 i białka fuzyjne IL-22 Fc i sposoby zastosowania

Also Published As

Publication number Publication date
WO2015067198A1 (en) 2015-05-14
CN105705160A (zh) 2016-06-22
EP3065765B1 (en) 2020-04-08
EP3065765A1 (en) 2016-09-14
AU2014346051A1 (en) 2016-05-26
JP6825181B2 (ja) 2021-02-03
CA2929637A1 (en) 2015-05-14
HK1223556A1 (zh) 2017-08-04
EP3065765A4 (en) 2017-08-02
US20160271221A1 (en) 2016-09-22
JP2019206548A (ja) 2019-12-05
CA2929637C (en) 2025-02-11
CN104623639A (zh) 2015-05-20
JP2016536357A (ja) 2016-11-24
AU2014346051B2 (en) 2020-02-27
CN105705160B (zh) 2020-02-07

Similar Documents

Publication Publication Date Title
EP3065765B1 (en) Use of il-22 dimers in manufacture of medicaments for treating pancreatitis
ES3026668T3 (en) Use of il-22 dimers in manufacture of a medicament for intravenous administration
AU2020401160B2 (en) Pharmaceutical TACI-Fc fusion protein formulation
ES2690147T3 (es) Apelina pegilada y usos de la misma
ES2819866T3 (es) Polipéptido ANGPTL8 y su uso para el tratamiento de condiciones asociadas con triglicéridos elevados
KR20200085763A (ko) 수술전, 수술동안 또는 수술후 투여용 glp-2 유사체 및 펩티바디
ES3031633T3 (en) Annexin a1 n-terminal peptide formulations and methods
ES2930351T3 (es) Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante
JP2017114867A (ja) ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
WO2020065063A1 (en) Formulations of glucagon-like-peptide-2 (glp-2) analogues
CN115605218B (zh) 用于治疗大疱性表皮松解症的归巢肽引导的核心蛋白聚糖缀合物
RU2833459C2 (ru) Составы аналогов глюкагоноподобного пептида-2 (glp-2)
RU2820132C2 (ru) Способ улучшения симптомов со стороны нижних мочевыводящих путей
RU2839726C2 (ru) Способ лечения симптомов со стороны нижних мочевыводящих путей с использованием фексапотида трифлутата
CN121175330A (zh) 溶瘤肽
HK1223556B (en) Use of il-22 dimers in manufacture of medicaments for treating pancreatitis
HK40002973A (en) An il-22 dimer for use in treating necrotizing enterocolitis
HK40002973B (en) An il-22 dimer for use in treating necrotizing enterocolitis